title: Local pulmonary immunotherapy with siRNA targeting TGFβ1 enhances antimicrobial capacity in Mycobacterium tuberculosis infected mice.
abstract: In this study we demonstrate that it is possible to shift the immune system during a chronic infection with Mycobacterium tuberculosis. TGFβ and IL10 cytokines inhibit the Th1 response during chronic pulmonary infection with M. tuberculosis. We show that intrapulmonary delivery of siRNA targeting TGFβ1 is able to reduce the pulmonary bacillary load in mice chronically infected with M. tuberculosis: an effect that appears to be partly dependent on IL10 expression. To demonstrate this, we induced gene silencing of tgfβ1 in the lungs of wild type and IL10 knockout mice using a non-invasive aerosolized intrapulmonary delivery of siRNA targeting TGFβ1. Five days after the last treatment with siRNA, the levels of tgfb1 transcripts and TGFβ1 protein were reduced when compared with control groups treated with RNase-free water or non-targeting siRNA. Mice treated with siRNA also had increased expression of the antimicrobial mediators (NO and iNOS) which effectively reduced the bacterial load by 0.17 and 0.47 log(10) in C57BL/6 and IL-10 KO mice respectively when compared with their respective control mice. More importantly, the bacterial load in siRNA treated IL-10 KO mice four weeks after the last treatment remained 0.32 log(10) lower than in control mice.
authors.affiliation: Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO 80523, USA.
authors.forename: Adrian G
authors.initials: AG
authors.lastname: Rosas-Taraco
authors.forename: David M
authors.initials: DM
authors.lastname: Higgins
authors.forename: Joaquín
authors.initials: J
authors.lastname: Sánchez-Campillo
authors.forename: Eric J
authors.initials: EJ
authors.lastname: Lee
authors.forename: Ian M
authors.initials: IM
authors.lastname: Orme
authors.forename: Mercedes
authors.initials: M
authors.lastname: González-Juarrero
mesh_terms: D000818:Animals; D016207:Cytokines / Q000276:immunology; D016753:Interleukin-10 / Q000276:immunology*; D008168:Lung / Q000276:immunology*; D008213:Lymphocyte Activation; D051379:Mice; D018345:Mice, Knockout; D009169:Mycobacterium tuberculosis / Q000276:immunology*; D034741:RNA, Small Interfering / Q000494:pharmacology*; D018417:Th1 Cells / Q000276:immunology; D053773:Transforming Growth Factor beta1 / Q000187:drug effects / Q000276:immunology*; D014397:Tuberculosis, Pulmonary / Q000276:immunology*
chemical_list: D016207:Cytokines; D034741:RNA, Small Interfering; D053773:Transforming Growth Factor beta1; D016753:Interleukin-10